AR-C69931MX is primarily used in research settings to study platelet aggregation and thrombosis. It acts as a potent and selective antagonist of the P2Y12 receptor, which plays a critical role in platelet activation. This makes it a valuable tool for investigating the mechanisms of blood clot formation and for developing antiplatelet therapies. Researchers utilize it to explore conditions like cardiovascular diseases, where abnormal clotting is a concern. Additionally, it aids in the evaluation of new drugs aimed at preventing thrombosis without excessive bleeding risks. Its specificity allows for precise studies on the P2Y12 receptor's role in various physiological and pathological processes.